Statement Of Financial Position [Abstract]

ABIONYX Pharma - Filing #2810725

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	335,000 EUR	—	—	—	—	—	373,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Goodwill	—	5 377 EUR	—	—	—	—	—	5 377 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	80,000 EUR	—	—	—	—	—	75,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	4 104 EUR	—	—	—	—	—	4 046 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets	—	14 834 EUR	—	—	—	—	—	15 823 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	1 623 EUR	—	—	—	—	—	1 418 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Share premium	—	12 572 EUR	—	—	—	—	—	8 599 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	158,000 EUR	7 922 EUR	6 341 EUR	12 572 EUR	1 623 EUR	103,000 EUR	193,000 EUR	7 169 EUR	192,000 EUR	8 599 EUR	2 937 EUR	229,000 EUR	1 418 EUR	126,000 EUR	201,000 EUR	169 829 EUR	10 677 EUR	10,000 EUR	179 214 EUR	87,000 EUR	1 396 EUR
Equity and liabilities	—	14 834 EUR	—	—	—	—	—	15 823 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—